Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: A cancer and leukemia group B study (CALGB 9062)

Antonius A. Miller, Gary L. Rosner, Mark J. Ratain, Donna R. Hollis, Mark R. Green, Richard L. Schilsky

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: A cancer and leukemia group B study (CALGB 9062)'. Together they form a unique fingerprint.

Medicine & Life Sciences